[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.173.45. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

September 2019 - April 2016

Decade

Year

Issue

April 2019, Vol 4, No. 4, Pages 305-393

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2019;4(4):305. doi:10.1001/jamacardio.2018.3190
Original Investigation

Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial

Abstract Full Text
free access
JAMA Cardiol. 2019;4(4):314-320. doi:10.1001/jamacardio.2019.0179

This secondary analysis of a randomized clinical trial examines whether longitudinal increases in high-sensitivity C-reactive protein levels during 16 weeks after an acute coronary syndrome are associated with increased risk of a major adverse cardiac event, cardiovascular death, and all-cause death.

Coronary Atherosclerotic Phenotype and Plaque Healing in Patients With Recurrent Acute Coronary Syndromes Compared With Patients With Long-term Clinical Stability: An In Vivo Optical Coherence Tomography Study

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2019;4(4):321-329. doi:10.1001/jamacardio.2019.0275

This study assesses in vivo the coronary atherosclerotic phenotype as well as the prevalence and characteristics of healed coronary plaques by optical coherence tomography imaging in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability.

Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices

Abstract Full Text
free access
JAMA Cardiol. 2019;4(4):332-340. doi:10.1001/jamacardio.2019.0325

This cohort study examines survival following treatment with drug-coated devices compared with non–drug-coated devices for Centers for Medicare and Medicaid Services beneficiaries who were admitted for femoropopliteal artery revascularization.

Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study

Abstract Full Text
JAMA Cardiol. 2019;4(4):342-352. doi:10.1001/jamacardio.2019.0295

This analysis of data from the 2016 Global Burden of Disease Study examines the national and province-level mortality, prevalence, and disability-adjusted life-years associated with cardiovascular disease in China from 1990 to 2016.

Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System

Abstract Full Text
free access
JAMA Cardiol. 2019;4(4):353-362. doi:10.1001/jamacardio.2019.0375

This cohort study assesses cardiovascular disease risks, incidence, hospitalization, and mortality among patients with end-stage renal disease aged 1 to 29 years to determine whether patients aged 22 to 29 years have risks that differ from those of younger patients.

Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study

Abstract Full Text
free access has audio
JAMA Cardiol. 2019;4(4):363-369. doi:10.1001/jamacardio.2019.0549

This community surveillance study uses data from communities in Maryland, Minnesota, Mississippi, and North Carolina to explore the association of monthly influenza-like illness activity with myocardial infarction and heart failure hospitalizations.

Brief Report

Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention

Abstract Full Text
JAMA Cardiol. 2019;4(4):370-374. doi:10.1001/jamacardio.2019.0175

This post hoc analysis of data from randomized clinical trials investigates the clinical value of fractional flow reserve in patients who have undergone percutaneous coronary intervention.

Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research

Abstract Full Text
open access
JAMA Cardiol. 2019;4(4):375-379. doi:10.1001/jamacardio.2019.0198

This study evaluates the challenges of using the Social Security Administration Death Master File mortality data, particularly for analyzing mortality trends among patients with atherosclerotic cardiovascular disease.

Viewpoint

MitraClip and Tertiary Mitral Regurgitation—Mitral Regurgitation Gets Curiouser and Curiouser

Abstract Full Text
JAMA Cardiol. 2019;4(4):307-308. doi:10.1001/jamacardio.2019.0195

This Viewpoint describes a novel type of mitral regurgitation and describes its treatment with a device called the MitraClip.

From the Heart

142 Days

Abstract Full Text
JAMA Cardiol. 2019;4(4):309-310. doi:10.1001/jamacardio.2019.0397

This first-person narrative includes the perspectives of a cardiology fellow, an attending physician, and a patient awaiting a heart-liver transplant on the experience of waiting for organs to become available.

Editorial

Two Randomized Clinical Trials on the Treatment of Secondary Mitral Regurgitation—Contradictory or Complementary?

Abstract Full Text
JAMA Cardiol. 2019;4(4):311-313. doi:10.1001/jamacardio.2019.0204

This Viewpoint discusses 2 randomized clinical trials of the MitraClip, a novel treatment for secondary mitral regurgitation.

Invited Commentary

Comparing the Risk Factors of Plaque Rupture and Failed Plaque Healing in Acute Coronary Syndrome

Abstract Full Text
JAMA Cardiol. 2019;4(4):329-331. doi:10.1001/jamacardio.2019.0312

Assessing the Long-term Safety of Endovascular Therapies—The Case of Peripheral Paclitaxel-Coated Devices

Abstract Full Text
free access
JAMA Cardiol. 2019;4(4):340-341. doi:10.1001/jamacardio.2019.0339
Review

Emerging Science for the Clinician

Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review

Abstract Full Text
JAMA Cardiol. 2019;4(4):380-387. doi:10.1001/jamacardio.2019.0302

This narrative review discusses the evidence for clonal hematopoiesis as a physiological factor connecting cancer and cardiovascular disease.

JAMA Cardiology Clinical Challenge

A Patient With Multiple Coronary Artery Aneurysms

Abstract Full Text
has active quiz
JAMA Cardiol. 2019;4(4):388-389. doi:10.1001/jamacardio.2018.4268

A man in his early 40s is admitted with acute chest pain and high serum concentrations of IgG4. What would you do next?

Comment & Response

Interpreting the Prognostic Value of Unrecognized Myocardial Infarction Among Older Adults

Abstract Full Text
JAMA Cardiol. 2019;4(4):391. doi:10.1001/jamacardio.2019.0184

Interpreting the Prognostic Value of Unrecognized Myocardial Infarction Among Older Adults—Reply

Abstract Full Text
JAMA Cardiol. 2019;4(4):391-392. doi:10.1001/jamacardio.2019.0207

Interpretation of Studies on the Occurrence of Atrial Fibrillation in Elite Athletes

Abstract Full Text
JAMA Cardiol. 2019;4(4):392. doi:10.1001/jamacardio.2019.0382

Interpretation of Studies on the Occurrence of Atrial Fibrillation in Elite Athletes

Abstract Full Text
JAMA Cardiol. 2019;4(4):392-393. doi:10.1001/jamacardio.2019.0385

Interpretation of Studies on the Occurrence of Atrial Fibrillation in Elite Athletes—Reply

Abstract Full Text
JAMA Cardiol. 2019;4(4):393. doi:10.1001/jamacardio.2019.0394
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2019;4(4):306. doi:10.1001/jamacardio.2018.3191
×